Clinical Trial Update: Decitabine for Myelodysplastic Syndromes and Acute Myeloid Leukemia Before Allogeneic Hematopoietic Cell Transplantation [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating decitabine given before allogeneic hematopoietic cell transplantation in patients with higher-risk myelodysplastic syndro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• Dacogen (decitabine)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Higher-risk Myelodysplastic Syndrome, Relapsed /Refractory Acute Myeloid Leukemia | Phase 4 | Status: UNKNOWN